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TECHNICAL NOTE
Measurement of glomerular filtration rate utilizing a single
subcutaneous injection of '251-iothalamate
ARNOLD H. ISRAELIT, DEWEY L. LONG, MARTIN G. WHITE and ALAN R. HULL
Department of Internal Medicine, University of Texas Southwestern Medical School,
and the Veterans Administration Hospital, Dallas, Texas
The measurement of glomerular filtration rate (GFR) is
an important index in the evaluation and follow-up of
patients with renal disease and transplant recipients. Un-
fortunately, its clinical usefulness was limited for many
years because of the difficulties associated with the measure-
ment of inulin clearance. Marked simplification in the
measurement of GFR occurred as a result of the introduc-
tion of radioactively-labeled iothalamate, a substance re-
ported to be handled by the kidney in an identical manner
as inulin [1 ].1 Sigman, Elwood and Knox [3], as well as
others [4—7], clearly demonstrated that the clearance of
isotopically labeled iothalamate, administered by con-
tinuous infusion, was identical to that of inulin over a wide
range of filtration rates. Subsequently, the measurement of
GFR was simplified further by the utilization of a single
intravenous injection of labeled iothalainate [8—10]. Un-
fortunately, the results obtained with the single intra-
venous injection have not been uniformly in agreement with
the simultaneously measured inulin clearance. Therefore,
a new technique for the administration of iothalamate has
been introduced.
In the present studies the feasibility and reliability of a
single subcutaneously administered injection of 125J..
iothalamate sodium was evaluated in the measurement of
GFR. Our results indicate that stable plasma concentra-
tions of iothalamate are achieved with the single sub-
cutaneous injection technique and that accurate and re-
producible measurements of GFR are obtained over a wide
range of renal function.
Evidence has recently been presented in the rat which demon-
strates that iothalamate is reabsorbed from tubular fluid when
the intratubular pressure is elevated [2].
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Methods. In 20 patients with renal disease and in two
normal subjects, simultaneous clearance studies were per-
formed with inulin and 1251-iothalamate (Glofil —125J,
Abbott Laboratories, Chicago). Each subject received
10 drops of Lugol's solution the evening prior to the study.
The following morning each subject was given an oral
water load (20 mI/kg body wt) to initiate a diuresis, and
throughout the study urinary output was replaced with
water. Following a loading dose (9 mg/kg), the plasma
inulin concentration was maintained by a constant i.v.
infusion at 10 mg/mm. This resulted in plasma concentra-
tions of approximately 10 mg/lOO ml. '251-iothalamate,
20 j.tCi, was mixed with 0.1 ml of 1: 1000 aqueous epi-
nephrine and administered subcutaneously in the deltoid
area. After 40 to 60 minutes of equilibration, 3 timed (25 to
35 mm) clearance determinations were performed. Urinary
samples were obtained by voluntary voiding. A venous
blood sample was obtained at the midpoint of each clear-
ance period.
Inulin concentrations in plasma and urine were measured
by the alkali-stable diphenylamine method [11]. The radio-
activity of 1251-iothalamate in plasma and urine was meas-
ured in 0.5 ml aliquots using a Packard Gamma Spectro-
meter (Model 3348).
The clearances of inulin and iothalamate were calculated
from the following formula: clearance = U >( V where
U =urine concentration of inulin or cpm of '251-iothala-
mate/mI urine, V =urine flow in mI/mm, and P =plasma
inulin concentration or cpm of '251-iothalamate/mI. Sta-
tistical analysis was performed to assess the significance of
the difference in mean values by Student's paired t test.
Simple least square regression analysis was performed.
The correlation coefficient, F test, and coefficients of varia-
tion were calculated.
Results. The subcutaneous administration of iothalamate
in epinephrine resulted in stable plasma iothalamate con-
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Fig. 1. Variation in plasma 1251-iothalamate activity in all patients
during consecutive clearance periods. The initial plasma 1251_
iothalamateactivity was arbitrarily designated 100% to normal-
ize for the wide variation in plasma lothalamate concentrations
between patients. The values for the second and third periods
represent the mean and standard error.
centrations in 20 out of 22 studies. In Fig. 1 the variation
in plasma iothalamate concentration during successive
clearance periods is expressed as percent of change from
the initial plasma concentration during the first clearance
period. The plasma concentration of iothalamate increased
slightly between the first and second clearance periods as
equilibrium was being approached. During the subsequent
period, no further increase in plasma iothalamate concen-
tration occurred, suggesting that equilibration between the
Fig. 2. Relationship between inulin and iothalamate clearances.
Each point (•) represents the mean of all clearance periods ob-
tained for each patient during the simultaneous measurement of
inulin and iothalamate clearance. The solid line represents the
line of identity and the broken line represents the least square
regression analysis. The correlation coefficient (r) = 0.97.
rates of absorption, distribution and excretion was present.
The stability of the plasma iothalamate concentration sup-
ports the use of a single midpoint plasma sample for the
calculation of iothalamate clearance.
The relationship between the simultaneously measured
inulin and 1251-iothalamate clearances is depicted in Fig. 2.
The solid line represents the line of identity. Each point
represents the mean of all clearance values for each patient.
The GFR ranged between 6 and 125 mI/mm. The mean
ratio of the clearance of '251-iothalamate to the clearance
of inulin was 1.05 which is not statistically different
from 1.00 (F> 0.5). The least square regression analysis of
the mean values yields a curve depicted by the broken line
of y=l.054x—3.069, where y=the clearance of 125J..
iothalamate, and x = the clearance of inulin. The correla-
tion coefficient (r) between the paired values =0.97, which
is highly significant. It is apparent from both the distribu-
tion of the points around the line of identity and r that the
clearance of iothalamate is an accurate measurement for
GFR over a wide range of renal function.
Discussion. Radioactive iothalamate has gained wide-
spread acceptance as a suitable substitute for inulin and has
extended the usefulness of the measurement of GFR in
man. More recently, several additional techniques [8—10]
have been introduced to further simplify the measurement
of GFR. These newer methods have utilized a single intra-
venous injection of iothalamate in conjunction with plasma
decay analyses, total body monitoring or standard clearance.
However, conflicting reports in regard to the usefulness of
the single intravenous injection have appeared [8, (L. V.
Fisher, personal communication)]. While Cangiano et al [8]
have reported a very close correlation between the clearance
of a single intravenous injection of iothalamate and inulin,
Fisher (personal communication) recently showed a very
poor correlation between the clearance of the two substances.
The factor(s) responsible for the discrepancy between the
studies is uncertain. One major limitation in the estimation of
GFR following a single intravenous injection is the necessity
ofassumingthatplasrnaclearance is equal to renal excretion.
While this assumption may be practical at normal filtration
rates in nonedematous patients, it is quite unlikely that it isva-
lid. In fact, Griep and NeIp [1] have shown in aglomerular fish
that iothalamate accumulates in bile and distributes itself
throughout most tissues. Therefore, it seems reasonable to
expect that as GFR decreases, the relative contribution of
extrarenal mechanisms to plasma clearance would increase.
Consequently, equating plasma clearance entirely to renal
excretion can result in erroneous estimates of GFR when
evaluating patients with edema or reduced filtration rates.
As a result of the discrepancy between the findings of in-
vestigators and the limitations imposed by reduced GFR
and edematous states, the usefulness of the single intra-
venous injection method has been questioned.
In the present studies a new technique for the administra-
tion of iothalamate has been utilized. The simultaneous
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clearances of subcutaneously administered iothalamate and
continuous intravenous infusion of inulin were compared
in patients with a wide range of filtration rates. Two im-
portant findings were noted in the present studies: 1) con-
stant plasma iothalamate concentrations lasting several
hours were obtained with a single subcutaneous injection
of iothalamate in epinephrine; and 2) the simultaneously
measured clearances of iothalamate and inulin were
identical.
The subcutaneous administration of iothalamate pro-
duced remarkably constant plasma concentrations (Fig. 1).
In fact, less variation in the plasma concentrations of
iothalamate was noted with this technique than with the
continuous infusion of iothalamate (unpublished observa-
tions). The constant plasma iothalamate concentration is
attributable to the addition of epinephrine which retarded
absorption from the injection site. In several additional
studies in which epinephrine was not mixed with the
iothalamate, both unstable plasma iothalamate concentra-
tions and variable clearance rates were noted. The dose of
aqueous epinephrine utilized in the present studies did not
produce symptoms in any patients, and serial measure-
ments of both blood pressure and pulse rate were un-
changed. Although the administration of comparable doses
of epinephrine has been associated at times with marked
cardiovascular alterations, GFR has remained unchanged
[121. It is, therefore, unlikely that any alteration in renal
function occurred in our patients as a result of the addition
of epinephrine.
The simultaneously measured clearance rates of inulin
and iothalamate were identical over a wide range of GFR
(Fig. 2). These results validate the reliability of the clearance
of subcutaneously administered 1251-iothalamate to measure
GFR at all levels of renal function. In addition to being
reliable, the clearance of subcutaneously administered
iothalamate is also reproducible. Fig. 3 shows the variation
in GFR between successive clearance periods expressed as
percent of change from the initial value for each patient.
During the three successive clearance periods, only minimal
variation in iothalamate clearance occurred. The maximum
coefficient of variation between successive periods ranged
between 2 and 10% in 21 out of 22 studies, while in a single
study it was 33 %. The mean maximal coefficient of varia-
tion was 7 1 %. Furthermore, variation in the rate of
'251-iothalamate clearance between successive periods was
significantly less (P<0.025) than the simultaneously deter-
mined inulin clearances which ranged between I and 47%
with a mean maximal coefficient of variation of 17 5%.
The implications of these findings provide for further
simplification of the measurement of GFR in both the
evaluation and follow-up of patients with renal disease and
transplant recipients. A single subcutaneous injection, an
oral water load, and the securance of one or more timed
clearance periods beginning 60 to 90 minutes following the
administration of iothalamate will provide an accurate and
reproducible index of GFR. The method also permits one
technical assistant to perform several measurements simul-
taneously. Furthermore, in special circumstances such as
transplant rejection, rapid evaluation of the GFR can be
obtained.
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Fig. 3. Variation in 1251-iothalamate clearance in all patients
during consecutive clearance periods. The initial '251-iothalamate
clearance was arbitrarily designated 100% to normalize between
patients. For each period the mean (•)and standard error are
shown.
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